In silico docking reveals possible riluzole binding sites on Nav1.6 sodium channel: implications for amyotrophic lateral sclerosis therapy (Q1790872)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: In silico docking reveals possible riluzole binding sites on Nav1.6 sodium channel: implications for amyotrophic lateral sclerosis therapy |
scientific article; zbMATH DE number 6946711
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | In silico docking reveals possible riluzole binding sites on Nav1.6 sodium channel: implications for amyotrophic lateral sclerosis therapy |
scientific article; zbMATH DE number 6946711 |
Statements
In silico docking reveals possible riluzole binding sites on Nav1.6 sodium channel: implications for amyotrophic lateral sclerosis therapy (English)
0 references
4 October 2018
0 references
amyotrophic lateral sclerosis
0 references
Nav1.6
0 references
riluzole
0 references
GLN 1799
0 references
0.5941194295883179
0 references
0.5824341177940369
0 references
0.5711389780044556
0 references
0.5518316030502319
0 references
0.5402463674545288
0 references
